A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients

doi:10.3748/wjg.15.2782

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 22

This Article

(0)

(5025)

(12)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Brief Article

World J Gastroenterol. Jun 14, 2009; 15(22): 2782-2786
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2782

Full Size Figure Download Figure

Figure 2 Changes in serum albumin, platelet count, and total bilirubin levels in chronic hepatitis C patients before and 24 wk after beginning the dose-up to 900 mg/d.

Citation: Sato S, Miyake T, Tobita H, Oshima N, Ishine J, Hanaoka T, Amano Y, Kinoshita Y. A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. World J Gastroenterol 2009; 15(22): 2782-2786
URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2782.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2782

Sato S, Miyake T, Tobita H, Oshima N, Ishine J, Hanaoka T, Amano Y, Kinoshita Y. A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. World J Gastroenterol 2009; 15(22): 2782-2786 [PMID: 19522030 DOI: 10.3748/wjg.15.2782]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.